VCIM

Velan Capital Investment Management Portfolio holdings

AUM $172M
1-Year Est. Return 385.14%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+385.14%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$172M
AUM Growth
+$65.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
56
New
Increased
Reduced
Closed

Top Buys

1
+$9.52M
2
+$8.75M
3
+$3.91M
4
TARA icon
Protara Therapeutics
TARA
+$3.87M
5
VRCA icon
Verrica Pharmaceuticals
VRCA
+$2.61M

Top Sells

1
+$5.96M
2
+$4.28M
3
+$3.78M
4
QURE icon
uniQure
QURE
+$1.87M
5
TELA icon
TELA Bio
TELA
+$1.11M

Sector Composition

1 Healthcare 100%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDSA icon
26
Edesa Biotech
EDSA
$62.5M
$976K 0.57%
687,500
ARWR icon
27
Arrowhead Research
ARWR
$10.4B
$432K 0.25%
6,500
VTYX
28
DELISTED
Ventyx Biosciences
VTYX
$361K 0.21%
40,000
CTMX icon
29
CytomX Therapeutics
CTMX
$997M
$341K 0.2%
80,000
PTGX icon
30
Protagonist Therapeutics
PTGX
$6.74B
$323K 0.19%
3,700
NRIX icon
31
Nurix Therapeutics
NRIX
$1.72B
$304K 0.18%
16,000
OVID icon
32
Ovid Therapeutics
OVID
$491M
$261K 0.15%
160,000
GOSS icon
33
Gossamer Bio
GOSS
$91.5M
$217K 0.13%
70,000
IMNM icon
34
Immunome
IMNM
$2.69B
$215K 0.13%
10,000
DSGN icon
35
Design Therapeutics
DSGN
$825M
$188K 0.11%
20,000
IMMX icon
36
Immix Biopharma
IMMX
$540M
$183K 0.11%
35,000
CNTX icon
37
Context Therapeutics
CNTX
$221M
$147K 0.09%
100,000
REPL icon
38
Replimune Group
REPL
$187M
$146K 0.08%
15,000
-5,000
LRMR icon
39
Larimar Therapeutics
LRMR
$474M
$126K 0.07%
33,000
XLO icon
40
Xilio Therapeutics
XLO
$49.7M
$109K 0.06%
+12,143
CRBP icon
41
Corbus Pharmaceuticals
CRBP
$186M
$106K 0.06%
13,000
-48,000
PRQR icon
42
ProQR Therapeutics
PRQR
$184M
$90.9K 0.05%
45,000
DTIL icon
43
Precision BioSciences
DTIL
$204M
$83.2K 0.05%
20,000
PYXS icon
44
Pyxis Oncology
PYXS
$118M
$46K 0.03%
40,000
-15,000
PMVP icon
45
PMV Pharmaceuticals
PMVP
$78.9M
$43.8K 0.03%
35,000
ACRS icon
46
Aclaris Therapeutics
ACRS
$532M
– –
-32,700
ALEC icon
47
Alector
ALEC
$270M
– –
-55,000
ELDN icon
48
Eledon Pharmaceuticals
ELDN
$303M
– –
-346,973
ERAS icon
49
Erasca
ERAS
$6.73B
– –
-65,000
GERN icon
50
Geron
GERN
$993M
– –
-80,000
1
2
3